recent articles
(PresseBox) (Hamburg, 20.07.2022) Mindpeak announces the CE-mark for another new product: Mindpeak Breast HER2 RoI (Region of Interest) supports pathologists in the scoring of digital images of breast cancer tissue, which underwent...
Ibex: Galen™ Gastric demonstrated outstanding outcomes in detecting gastric cancer in a multi-site study, supporting quality diagnosis, enhanced lab efficiency and quality control Tel Aviv, Israel, June 15, 2022 – Ibex Medical...
Proscia: Regulatory milestone to accelerate company’s international growth amid expanding presence in Europe PHILADELPHIA–(BUSINESS WIRE)– Proscia, a leader in digital and computational pathology solutions, today...
Albuquerque, NM, 10 January, 2022 – Indica Labs, a leading provider of computational pathology software and services, is proud to announce that following ISO13485 certification, HALO AP® has received a CE Mark for use in primary diagnosis...
Proscia Offers Concentriq Dx for Remote Use in Clinical Practice Du...
- Advocacy
- Anatomic Pathology
- Artificial Intelligence
- Clinical Laboratories
- Cloud Computing
- Current Affairs
- Data Management
- Device Manufacturers
- Digital Pathology News
- Education
- File format
- Government
- Health Technology Collaboration
- Image Analysis
- Laboratory Compliance
- Laboratory Informatics
- Laboratory Management & Operations
- Pathology News
- TeleHealth
- Vendor products
- Web/Tech
- Whole slide
The FDA has issued guidance aimed at expanding the use of remote digital pathology devices during the COVID-19 pandemic. In response to the FDA’s guidance, Proscia announced today that we are now offering our Concentriq Dx digital...
CE Mark enables Proscia’s entry into international anatomic pathology market Philadelphia – November 6, 2019 – Proscia, a leading provider of digital pathology software, has received a CE Mark for its Concentriq Dx solution for use in...
